Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

In vitro profile supports first-in-human study of GSK-2336805 for hepatitis C

April 18, 2011

Promising data disclosed from PEPPER trial of Pantera Lux paclitaxel-releasing balloon

April 18, 2011

REP-9AC shows promise as a therapy for hepatitis B

April 15, 2011

Preclinical data suggest benefit of allopurinol in diabetes-related nephropathy

April 15, 2011

AstraZeneca presents potent new MAPK 14 inhibitors

April 15, 2011

ASP-3026 shows antitumor activity in murine model of NSCLC

April 15, 2011

Carbamate-based NCEH inhibitor AX-13057 shows promising potency

April 15, 2011

EMD-1204831 shows antitumor activity in preclinical studies

April 15, 2011

Clinical phase I and II data presented on TMC-435 for hepatitis C

April 15, 2011

Acetone level in exhaled breath as a new biomarker of heart failure

April 15, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.